[Dispersion of ventricular recovery time as a new marker of arrhythmogenic risk]

Cardiologia. 1995 May;40(5):355-60.
[Article in Italian]
No abstract available

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Amiodarone / therapeutic use
  • Anti-Arrhythmia Agents / therapeutic use
  • Arrhythmias, Cardiac / etiology*
  • Arrhythmias, Cardiac / prevention & control
  • Coronary Disease / physiopathology
  • Electrocardiography*
  • Electrophysiology
  • Humans
  • Myocardial Infarction / physiopathology
  • Risk Factors
  • Vasodilator Agents / therapeutic use
  • Ventricular Function*

Substances

  • Adrenergic beta-Antagonists
  • Anti-Arrhythmia Agents
  • Vasodilator Agents
  • Amiodarone